Mometasone furoate 0.1%-salicylic acid 5% ointment twice daily versus fluocinonide 0.05% ointment twice daily in the management of patients with psoriasis

Clinical Therapeutics

Volumn 19, Issue 4, 1997, Pages 701-709

  Medansky, Roland S ^a   Cuffie, Cynthia A ^b   Tanner, Daniel J ^b  

^a Schering Plough Research Institute ^*  (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Fluocinonide; Mometasone fuorate salicylic acid; Psoriasis; Topical

Indexed keywords

FLUOCINONIDE; MOMETASONE FUROATE; SALICYLIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; OINTMENT; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

EID: 0030754667     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(97)80094-X     Document Type: Article

References (11)

1. Greaves MW, Weinstein GD. Treatment of psoriasis. NEJM. 1995;332:581-588.
2. Phillips TJ. Current treatment options in psoriasis. Hosp Pract. 1996;52:155-166.
3. Trozak DJ. Topical corticosteroid therapy in psoriasis vulgaris. Cutis. 1990;47: 341-350.
4. Weirich EG. Dermatopharmacology of salicylic acid. I. Range of dermatotherapeutic effects of salicylic acid. Dermatologica. 1975;151:268-273.
5. ® Physicians' Desk Reference. 51st ed. Montvale, NJ: Medical Economics Company, Inc.; 1997:2494-2495.
6. Svensson A, Reidhav I, Gisslen P, et al. A comparative study of mometasone furoate ointment and betamethasone valerate ointment in patients with psoriasis vulgaris. Curr Ther Res. 1992;52:390-396.
7. Katz HI, Prawer SE, Watson MJ, et al. Mometasone furoate ointment 0.1% vs hydrocortisone ointment 1.0% in psoriasis. Int J Dermatol. 1989;28:342-344.
8. Medansky RS, Bressinck R, Cole GW, et al. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: Comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent. Cutis. 1988;42:480-485.
9. Rosenthal D, Duke E. A clinical investigation of the efficacy and safety of mometasone furoate ointment 0.1% vs betamethasone valerate ointment 0.1% in the treatment of psoriasis. Curr Ther Res. 1988;49:790-801.
10. Medansky RS, Brody NI, Kanof NB, et al. Clinical investigations of mometasone furoate - a novel, nonfluorinated, topical corticosteroid. Semin Dermatol. 1987;6: 94-100.
11. Savin RC, Stoughton RB, Cornell RC, et al. Comparative study of desoximetasone ointment 0.25% versus fluocinonide 0.05% ointment in patients with psoriasis. Clin Ther. 1985;8:118-125.